Key Highlights: Implications: This is a strategic diversification move: Anupam Rasayan is using Bliss GVS to enter pharmaceutical formulations and move further up the healthcare value chai...
Key Highlights: Implications: This means Skymap Pharma is set to take over IMPCL as the government exits ownership, turning a long-running public-sector Ayurvedic and Unani manuf...
Key Highlights: Implications: GTBL’s MicroBiopharm acquisition is a strategic move to become a more integrated, higher-value pharma services and ingredients player. The mai...
Key Highlights: Implications: Rubicon is using the Arinna deal to buy its way into India’s fast‑growing CNS and neuro‑psychiatry market with an immediately revenue‑accretive, chr...
